RANDOMISED COMPARISON OF CISPLATIN WITH CYCLOPHOSPHAMIDE/CISPLATIN AND WITH CYCLOPHOSPHAMIDE/DOXORUBICIN/ CISPLATIN IN ADVANCED OVARIAN CANCER
- 1 August 1987
- journal article
- Published by Elsevier in The Lancet
- Vol. 330 (8555) , 353-359
- https://doi.org/10.1016/s0140-6736(87)92381-6
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- European studies with cisplatin and cisplatin analogs in advanced ovarian cancerEuropean Journal of Cancer and Clinical Oncology, 1986
- Hexamethylmelamine, adriamycin, and cyclophosphamide (HAC) versus cis-dichlorodiamineplatinum, adriamycin, and cyclophosphamide (PAC) in advanced ovarian cancer: A randomized clinical trialCancer Chemotherapy and Pharmacology, 1985
- Common Epithelial Cancer of the OvaryNew England Journal of Medicine, 1985
- Common Epithelial Cancer of the OvaryNew England Journal of Medicine, 1985
- RANDOMISED TRIAL COMPARING TWO COMBINATION CHEMOTHERAPY REGIMENS (HEXA-CAF VS CHAP-5) IN ADVANCED OVARIAN CARCINOMAThe Lancet, 1984
- RANDOMISED TRIAL COMPARING LOW-DOSE CISPLATIN AND CHLORAMBUCIL WITH LOW-DOSE CISPLATIN, CHLORAMBUCIL, AND DOXORUBICIN IN ADVANCED OVARIAN CARCINOMAThe Lancet, 1981
- Reporting results of cancer treatmentCancer, 1981
- A review of clinical experience with cis-platinum diammine dichloride : 1972–1978Biochimie, 1978
- Advanced Ovarian AdenocarcinomaNew England Journal of Medicine, 1978
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958